-
Global medicine news GSK/Sanofi new crown vaccine "2.0 version" enters Phase 2 clinical trial, AbbVie JAK inhibitor Phase 3 clinical success
Time of Update: 2021-07-25
On February 22, local time, Sanofi and GlaxoSmithKline (GSK) jointly announced that after adjustments, the new version of the adjuvant-based recombinant protein-based new coronary pneumonia (COVID-19) vaccine jointly developed by the two parties entered Phase 2 clinical trials.
-
New medicine for myeloma! Sanofi CD38 Antibody Sarclisa Combination Therapy Phase III Clinically Significantly Prolonged ProgressIon Survival, Deep Remission!
Time of Update: 2020-06-17
, June 10, 2020 / BIOON/Sanofi has announced positive results from a clinical trial of CD38-targeted antibody drug Sarclisa (isatumab) for recurrent and/or refractable multiple myeloma (MM) PHASE I
-
Look at the performance of Sanofi in China, the manufacturer of "anticoagulant first medicine".
Time of Update: 2020-06-03
Medicines Network February 7, 2016, Sanofi announced a break-up with Minsheng Pharmaceuticals, shocked most of the pharmaceutical community Although Sanofi's joint venture has not been smooth, its o
-
Practice open cooperation and promote pharmaceutical innovation: Sanofi and Suzhou Institute
Time of Update: 2017-03-13
In order to promote exchanges in this field, Sanofi Asia Pacific R & D headquarters and the center for systems medicine of the Chinese Academy of Medical Sciences and Suzhou Institute of systems medi
-
Sanofi's patent medicine was shortlisted and 50% of the price was cut
Time of Update: 2013-06-05
2013-06-05 source: which is the priority between daily economic news price and market? Recently, according to the notice on confirmation of shortlisted price for supplementary entry into primary medic